GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration

BioMed Research International - Tập 2015 - Trang 1-7 - 2015
Loren Pickart1, Jessica Michelle Vasquez-Soltero1, Anna Margolina1
1Skin Biology, Research & Development Department, 4122 Factoria Boulevard, SE Suite No. 200 Bellevue, WA 98006, USA.

Tóm tắt

GHK (glycyl-L-histidyl-L-lysine) is present in human plasma, saliva, and urine but declines with age. It is proposed that GHK functions as a complex with copper 2+ which accelerates wound healing and skin repair. GHK stimulates both synthesis and breakdown of collagen and glycosaminoglycans and modulates the activity of both metalloproteinases and their inhibitors. It stimulates collagen, dermatan sulfate, chondroitin sulfate, and the small proteoglycan, decorin. It also restores replicative vitality to fibroblasts after radiation therapy. The molecule attracts immune and endothelial cells to the site of an injury. It accelerates wound-healing of the skin, hair follicles, gastrointestinal tract, boney tissue, and foot pads of dogs. It also induces systemic wound healing in rats, mice, and pigs. In cosmetic products, it has been found to tighten loose skin and improve elasticity, skin density, and firmness, reduce fine lines and wrinkles, reduce photodamage, and hyperpigmentation, and increase keratinocyte proliferation. GHK has been proposed as a therapeutic agent for skin inflammation, chronic obstructive pulmonary disease, and metastatic colon cancer. It is capable of up- and downregulating at least 4,000 human genes, essentially resetting DNA to a healthier state. The present review revisits GHK’s role in skin regeneration in the light of recent discoveries.

Từ khóa


Tài liệu tham khảo

1973

10.1038/288715a0

1985, Surgical Forum, 25, 573

1987, Iamin: a human growth factor with multiple wound-healing properties, 273

10.1016/0024-3205(92)90504-i

10.1016/s0024-3205(00)00803-1

10.1046/j.1523-1747.2000.00166.x

2001, Archives of Facial Plastic Surgery, 3, 28, 10.1001/archfacial.qoa90013.28

1995, Archives Internationales de Pharmacodynamie et de Therapie, 330, 345

10.1111/j.1365-3164.2007.00647.x

10.1111/j.1365-3164.2006.00551.x

10.1016/j.lfs.2006.09.018

10.1111/j.1532-950X.2003.00515.x

1996, American Journal of Veterinary Research, 57, 394

10.1163/156856208784909435

10.1186/gm371

10.1007/s10585-010-9305-4

2012, Acta Poloniae Pharmaceutica, 69, 1303

10.1155/2014/151479

10.1186/gm367

10.1089/wound.2012.0394

10.1189/jlb.0407255

10.4172/2155-952X.1000144

10.6000/1927-7229.2014.03.02.2

10.1007/s00403-009-0942-x

10.1002/psc.2455

10.1016/j.actbio.2014.01.020

10.1001/archfaci.7.1.27

10.1016/s1088-3371(98)00011-4

2002

2005, Copper peptide and skin, 549

2008, Journal of Cosmetic Science, 59, 59

10.1007/s00011-010-0214-4

10.1007/s00011-010-0238-9

10.1002/jbm.b.30246

10.3109/10837450.2014.979944

10.3109/03639045.2011.569934

10.1046/j.1365-2230.1998.00310.x

10.1111/j.1600-0846.1998.tb00081.x

10.1046/j.1365-4362.1998.00231.x

10.1111/j.1600-0536.1999.tb06035.x

1981, Biochemical Journal, 199, 649, 10.1042/bj1990649

10.1016/s0020-1693(00)82544-x

10.1021/bi00262a004

10.1016/0076-6879(87)47121-8

10.1016/j.jpba.2008.02.012

1995, Cellular and Molecular Biology (Noisy-le-Grand, France), 41, 1081

10.1248/bpb.22.999

10.1016/0014-5793(88)80509-x

10.1083/jcb.125.4.929

10.1111/j.1524-475X.2009.00466.x

2010, Experimental Biology and Medicine, 4, 15

2006, Experimental Biology and Medicine, 3, 11